These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 38762916)
1. Discovery of meisoindigo derivatives as noncovalent and orally available M Gao Q; Liu S; Zhou Y; Fan J; Ke S; Zhou Y; Fan K; Wang Y; Zhou Y; Xia Z; Deng X Eur J Med Chem; 2024 Jul; 273():116498. PubMed ID: 38762916 [TBL] [Abstract][Full Text] [Related]
2. Discovery of highly potent SARS-CoV-2 M Chen W; Feng B; Han S; Wang P; Chen W; Zang Y; Li J; Hu Y Bioorg Med Chem Lett; 2022 Feb; 58():128526. PubMed ID: 34998903 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M Ghosh A; Chakraborty M; Chandra A; Alam MP J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023 [TBL] [Abstract][Full Text] [Related]
4. Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors. Huff S; Kummetha IR; Tiwari SK; Huante MB; Clark AE; Wang S; Bray W; Smith D; Carlin AF; Endsley M; Rana TM J Med Chem; 2022 Feb; 65(4):2866-2879. PubMed ID: 34570513 [TBL] [Abstract][Full Text] [Related]
6. Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity. Hamdy R; Fayed B; Mostafa A; Shama NMA; Mahmoud SH; Mehta CH; Nayak Y; M Soliman SS Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445763 [TBL] [Abstract][Full Text] [Related]
7. Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies. Diniz LRL; Perez-Castillo Y; Elshabrawy HA; Filho CDSMB; de Sousa DP Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33430299 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in silico inhibitory action studies of azo-anchored imidazo[4,5-b]indole scaffolds against the COVID-19 main protease (M Geedkar D; Kumar A; Sharma P Sci Rep; 2024 May; 14(1):10419. PubMed ID: 38710746 [TBL] [Abstract][Full Text] [Related]
9. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study. Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y Arch Med Res; 2021 Jan; 52(1):38-47. PubMed ID: 32962867 [TBL] [Abstract][Full Text] [Related]
10. Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2. Fischer A; Sellner M; Mitusińska K; Bzówka M; Lill MA; Góra A; Smieško M Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669738 [TBL] [Abstract][Full Text] [Related]
11. An Updated Review on SARS-CoV-2 Main Proteinase (M Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134 [TBL] [Abstract][Full Text] [Related]
13. Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease. Dou X; Sun Q; Xu G; Liu Y; Zhang C; Wang B; Lu Y; Guo Z; Su L; Huo T; Zhao X; Wang C; Yu Z; Song S; Zhang L; Liu Z; Lai L; Jiao N Eur J Med Chem; 2022 Aug; 238():114508. PubMed ID: 35688005 [TBL] [Abstract][Full Text] [Related]
14. Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors. Kitamura N; Sacco MD; Ma C; Hu Y; Townsend JA; Meng X; Zhang F; Zhang X; Ba M; Szeto T; Kukuljac A; Marty MT; Schultz D; Cherry S; Xiang Y; Chen Y; Wang J J Med Chem; 2022 Feb; 65(4):2848-2865. PubMed ID: 33891389 [TBL] [Abstract][Full Text] [Related]
15. Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease. Yuda GPWC; Hanif N; Hermawan A Daru; 2024 Jun; 32(1):47-65. PubMed ID: 37907683 [TBL] [Abstract][Full Text] [Related]
19. Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M Tejera E; Munteanu CR; López-Cortés A; Cabrera-Andrade A; Pérez-Castillo Y Molecules; 2020 Nov; 25(21):. PubMed ID: 33172092 [TBL] [Abstract][Full Text] [Related]
20. Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors. Breidenbach J; Lemke C; Pillaiyar T; Schäkel L; Al Hamwi G; Diett M; Gedschold R; Geiger N; Lopez V; Mirza S; Namasivayam V; Schiedel AC; Sylvester K; Thimm D; Vielmuth C; Phuong Vu L; Zyulina M; Bodem J; Gütschow M; Müller CE Angew Chem Int Ed Engl; 2021 Apr; 60(18):10423-10429. PubMed ID: 33655614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]